DehydraTech Drug-Delivery Technology by Lexaria Bioscience Corp

It’s only a matter of time before you become familiar with Lexaria Bioscience Corp., a global innovator in drug-delivery technology. The company is active in the cannabidiol (CBD) and hemp categories, and its DehydraTech delivery technology has been used to improve the effectiveness of both orally ingestible and topical products. Companies such as Altria Group, Cannadips and 1906 Chocolates have all partnered with Lexaria to bring their brands and products to life in new and exciting ways. Leading that charge and transformation at Lexaria is its CEO, Chris Bunka, a venture capital investor who has been with the company since its pivot into bioscience a little over five years ago.

As a venture capital investor, Bunka has a track record of investing in a number of biotech companies that extends as far back as 20 years ago. Bunka was an early investor in Lexaria over 10 years ago, an investment opportunity…

Continue Reading On: thehempbusinessmagazine.com